About Index Trending news
Analyze
Top 50 Pricing
Cytomedix, Inc.

Cytomedix, Inc.

Work at Cytomedix, Inc.? Add yourself to this profile

Cytomedix, Inc.

Cytomedix, Inc. is an autologous regenerative therapies company commercializing innovative platelet and stem cell technologies OTCQX: CMXI

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding
Post-IPO debt
$35,000,000
Private equity
$27,500,000
Employees

Unknown size

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Cytomedix, Inc. makes some noise.